CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-30 | Domzalski David President and CEO | Shares withheld for taxes | −6,239 | $1.66 | $10K | 1,309,727 |
| 2020-09-10 | LEPORE PATRICK G Director | Grant or award · Stock Options | +45,000 | 45,000 | ||
| 2020-09-08 | Saik Andrew Chief Financial Officer | Purchase | +40,000 | $1.46 | $58K | 340,000 |
| 2020-09-08 | Domzalski David President and CEO | Purchase | +75,000 | $1.38 | $104K | 1,315,966 |
| 2020-08-20 | BARBARI SHARON Director | Exercise or conversion | +75,000 | $1.48 | $111K | 75,000 |
| 2020-08-20 | BARBARI SHARON Director | Exercise or conversion · Stock Options | −75,000 | 13,971 | ||
| 2020-08-03 | Bright Rex Director | Grant or award · Stock Options | +22,500 | 22,500 | ||
| 2020-08-03 | Sandoval Elisabeth Director | Grant or award · Stock Options | +22,500 | 22,500 | ||
| 2020-08-03 | Bruno Anthony D Director | Grant or award · Stock Options | +22,500 | 22,500 | ||
| 2020-08-03 | Basta Steven L Director | Grant or award · Stock Options | +22,500 | 22,500 | ||
| 2020-08-03 | BARBARI SHARON Director | Grant or award · Stock Options | +22,500 | 22,500 | ||
| 2020-06-30 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −1,541 | $1.73 | $3K | 352,425 |
| 2020-06-30 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −2,378 | $1.73 | $4K | 291,018 |
| 2020-06-30 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −1,822 | $1.73 | $3K | 318,887 |
| 2020-06-30 | Domzalski David President and CEO | Shares withheld for taxes | −6,239 | $1.73 | $11K | 1,240,966 |
| 2020-06-09 | PERCEPTIVE ADVISORS LLC 10% owner | Purchase | +2,702,702 | $1.85 | $5.0M | 22,876,410 |
| 2020-05-06 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +150,000 | 353,967 | ||
| 2020-05-06 | Wiley Matthew T. Chief Commercial Officer | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2020-05-06 | Stuart Iain Chief Scientific Officer | Grant or award | +112,500 | 293,401 | ||
| 2020-05-06 | Stuart Iain Chief Scientific Officer | Grant or award · Stock Options | +112,500 | 112,500 |
Page 12 of 22 · 425 trades